 |
|
|
| |
Durable efficacy and safety of DTG + 3TC in treatment-naive people
with HIV-1 stratified by age: 144-week results from GEMINI-1 and -2
|
| |
| |
EACS 2021 Oct 27-30
F. Spinelli1, M. Prakash2, J. Slater1, R. Grove3, B. Wynne1, J. van Wyk2, A. Clark2
1ViiV Healthcare, Research Triangle Park, United States, 2ViiV Healthcare, Brentford, United Kingdom, 3GlaxoSmithKline, Brentford, United Kingdom
|
| |
|
|
|
|
|
